Literature DB >> 11109058

Clara-cell secretory protein in preterm infants' tracheal aspirates correlates with maturity and increases in infection.

P Lassus1, T J Nevalainen, J U Eskola, S Andersson.   

Abstract

Clara-cell secretory protein (CCSP), produced primarily by Clara cells in the conducting airways, is the most abundant soluble protein in pulmonary lavage fluid. CCSP is thought to be an immunosuppressive or anti-inflammatory protein with protective functions in the respiratory tract against exaggerated inflammatory reactions. CCSP was measured in 98 tracheoalveolar fluid (TAF) samples from 24 preterm infants (gestational age, 27.9 +/- 2.3 weeks, birth weight 1,020 +/- 305 g) with respiratory distress syndrome during the first 2 postnatal weeks. The ratio of urea-N in serum and in TAF was used to correct for dilution of TAF samples. Concentration of CCSP in TAF when corrected for dilution increased from 3.6 +/- 11 microg/mL on day 1 to 29.6 +/- 6.9 microg/mL on day 14. CCSP correlated with gestational age. A negative correlation was found between CCSP and inspiratory oxygen concentration, and a positive correlation between CCSP and both arterial pH and base excess during the first 2 postnatal weeks. Infants with clinical and laboratory signs of infection had higher CCSP than noninfected infants, and a negative correlation was found between CCSP and leukocyte count during the first 2 postnatal weeks (all P < 0.05). We suggest that pulmonary CCSP correlates with both gestational and postnatal age, and increases in response to infection in infants with respiratory distress during the early postnatal period. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11109058     DOI: 10.1002/1099-0496(200012)30:6<466::aid-ppul5>3.0.co;2-x

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  8 in total

1.  Clara cell secretory protein (CC16) as a peripheral blood biomarker of lung injury in ventilated preterm neonates.

Authors:  Kosmas Sarafidis; Theodora Stathopoulou; Elisavet Diamanti; Vasiliki Soubasi; Charalambos Agakidis; Aikaterini Balaska; Vasiliki Drossou
Journal:  Eur J Pediatr       Date:  2008-06-03       Impact factor: 3.183

2.  Clara cell secretory protein and bronchopulmonary dysplasia in prematurely born infants.

Authors:  Anne Greenough
Journal:  Eur J Pediatr       Date:  2008-05-22       Impact factor: 3.183

3.  Cord blood Clara cell protein CC16 predicts the development of bronchopulmonary dysplasia.

Authors:  Alexandra J J Schrama; Alfred Bernard; Ben J H M Poorthuis; Aeilko H Zwinderman; Howard M Berger; Frans J Walther
Journal:  Eur J Pediatr       Date:  2008-06-03       Impact factor: 3.183

Review 4.  Intratracheal Clara cell secretory protein (CCSP) administration in preterm infants with or at risk of respiratory distress syndrome.

Authors:  Mohamed E Abdel-Latif; David A Osborn
Journal:  Cochrane Database Syst Rev       Date:  2011-05-11

5.  Biomarkers of inflammation in infants with cystic fibrosis.

Authors:  Theresa A Laguna; Cynthia B Williams; Myra G Nunez; Cole Welchlin-Bradford; Catherine E Moen; Cavan S Reilly; Chris H Wendt
Journal:  Respir Res       Date:  2018-01-08

6.  Pulmonary Biomarkers of Bronchopulmonary Dysplasia.

Authors:  Alecia Thompson; Vineet Bhandari
Journal:  Biomark Insights       Date:  2008-07-02

7.  Neonatal hyperoxic exposure persistently alters lung secretoglobins and annexin A1.

Authors:  Thomas M Raffay; Morgan L Locy; Cynthia L Hill; Nik S Jindal; Lynette K Rogers; Stephen E Welty; Trent E Tipple
Journal:  Biomed Res Int       Date:  2013-09-26       Impact factor: 3.411

Review 8.  Biomarkers in Pediatric ARDS: Future Directions.

Authors:  Benjamin E Orwoll; Anil Sapru
Journal:  Front Pediatr       Date:  2016-06-01       Impact factor: 3.418

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.